Business · 11/09/2019Updated: 10/17/2026 · 1 min read
FDA to Hold Public Hearing on Fecal Microbiota Transplantation for C. difficile Infection
Summary
The FDA is seeking public input on the use of fecal microbiota transplantation to treat C. difficile infections that are not responsive to standard therapies, as part of its ongoing consideration of this treatment approach.